ID   P4K2A_RAT               Reviewed;         478 AA.
AC   Q99M64;
DT   01-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-2001, sequence version 1.
DT   02-OCT-2024, entry version 142.
DE   RecName: Full=Phosphatidylinositol 4-kinase type 2-alpha;
DE            EC=2.7.1.67 {ECO:0000269|PubMed:11244087};
DE   AltName: Full=55 kDa type II phosphatidylinositol 4-kinase;
DE   AltName: Full=Phosphatidylinositol 4-kinase type II-alpha;
GN   Name=Pi4k2a; Synonyms=Pi4kii;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR
RP   LOCATION, AND PALMITOYLATION.
RC   TISSUE=Brain;
RX   PubMed=11244087; DOI=10.1074/jbc.c000861200;
RA   Barylko B., Gerber S.H., Binns D.D., Grichine N., Khvotchev M.,
RA   Suedhof T.C., Albanesi J.P.;
RT   "A novel family of phosphatidylinositol 4-kinases conserved from yeast to
RT   humans.";
RL   J. Biol. Chem. 276:7705-7708(2001).
RN   [2]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-46 AND SER-50, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=16641100; DOI=10.1073/pnas.0600895103;
RA   Hoffert J.D., Pisitkun T., Wang G., Shen R.-F., Knepper M.A.;
RT   "Quantitative phosphoproteomics of vasopressin-sensitive renal cells:
RT   regulation of aquaporin-2 phosphorylation at two sites.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:7159-7164(2006).
RN   [3]
RP   TISSUE SPECIFICITY.
RX   PubMed=19581584; DOI=10.1073/pnas.0903011106;
RA   Simons J.P., Al-Shawi R., Minogue S., Waugh M.G., Wiedemann C.,
RA   Evangelou S., Loesch A., Sihra T.S., King R., Warner T.T., Hsuan J.J.;
RT   "Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset
RT   degeneration of spinal cord axons.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:11535-11539(2009).
RN   [4]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF LEU-60 AND LEU-61, SUBUNIT, AND
RP   INTERACTION WITH BLOC1S5 AND DTNBP1.
RX   PubMed=21998198; DOI=10.1091/mbc.e11-07-0592;
RA   Larimore J., Tornieri K., Ryder P.V., Gokhale A., Zlatic S.A., Craige B.,
RA   Lee J.D., Talbot K., Pare J.F., Smith Y., Faundez V.;
RT   "The schizophrenia susceptibility factor dysbindin and its associated
RT   complex sort cargoes from cell bodies to the synapse.";
RL   Mol. Biol. Cell 22:4854-4867(2011).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-5; SER-9; SER-46 AND SER-461,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22673903; DOI=10.1038/ncomms1871;
RA   Lundby A., Secher A., Lage K., Nordsborg N.B., Dmytriyev A., Lundby C.,
RA   Olsen J.V.;
RT   "Quantitative maps of protein phosphorylation sites across 14 different rat
RT   organs and tissues.";
RL   Nat. Commun. 3:876-876(2012).
CC   -!- FUNCTION: Membrane-bound phosphatidylinositol-4 kinase (PI4-kinase)
CC       that catalyzes the phosphorylation of phosphatidylinositol (PI) to
CC       phosphatidylinositol 4-phosphate (PI4P), a lipid that plays important
CC       roles in endocytosis, Golgi function, protein sorting and membrane
CC       trafficking and is required for prolonged survival of neurons. Besides,
CC       phosphorylation of phosphatidylinositol (PI) to phosphatidylinositol 4-
CC       phosphate (PI4P) is the first committed step in the generation of
CC       phosphatidylinositol 4,5-bisphosphate (PIP2), a precursor of the second
CC       messenger inositol 1,4,5-trisphosphate (InsP3).
CC       {ECO:0000269|PubMed:11244087, ECO:0000305}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a 1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol) + ATP = a
CC         1,2-diacyl-sn-glycero-3-phospho-(1D-myo-inositol 4-phosphate) + ADP +
CC         H(+); Xref=Rhea:RHEA:19877, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:57880, ChEBI:CHEBI:58178, ChEBI:CHEBI:456216;
CC         EC=2.7.1.67; Evidence={ECO:0000269|PubMed:11244087};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=88 uM for ATP;
CC         KM=45 uM for PtdIns;
CC   -!- SUBUNIT: Associates with the BLOC-1 and the AP-3 complexes; the BLOC-1
CC       complex is required for optimal binding of PI4K2A to the AP-3 complex.
CC       Interacts with BLOC1S5 and DTNBP1 (PubMed:21998198). Interacts with
CC       FOS; this interaction may enhance phosphatidylinositol phosphorylation
CC       activity (By similarity). Interacts with ITCH (By similarity).
CC       Interacts with ATG9A (By similarity). {ECO:0000250|UniProtKB:Q2TBE6,
CC       ECO:0000269|PubMed:21998198}.
CC   -!- SUBCELLULAR LOCATION: Golgi apparatus, trans-Golgi network membrane
CC       {ECO:0000250|UniProtKB:Q9BTU6}; Lipid-anchor
CC       {ECO:0000250|UniProtKB:Q9BTU6}. Membrane raft
CC       {ECO:0000250|UniProtKB:Q9BTU6}. Endosome {ECO:0000269|PubMed:21998198}.
CC       Endosome membrane {ECO:0000250|UniProtKB:Q9BTU6}. Cytoplasmic vesicle
CC       {ECO:0000269|PubMed:21998198}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q2TBE6}. Presynaptic cell membrane
CC       {ECO:0000250|UniProtKB:Q2TBE6}. Synapse, synaptosome
CC       {ECO:0000250|UniProtKB:Q2TBE6}. Mitochondrion
CC       {ECO:0000250|UniProtKB:Q2TBE6}. Membrane {ECO:0000269|PubMed:11244087};
CC       Lipid-anchor {ECO:0000269|PubMed:11244087}. Cell membrane
CC       {ECO:0000250|UniProtKB:Q9BTU6}. Perikaryon
CC       {ECO:0000250|UniProtKB:Q2TBE6}. Cell projection, neuron projection
CC       {ECO:0000250|UniProtKB:Q2TBE6}. Note=Found in subdomains of the plasma
CC       membrane termed non-caveolar membrane rafts. Transported from neuronal
CC       cell body to neuron projections and neurite tips in a BLOC-1- and AP-3-
CC       complexes-dependent manner. {ECO:0000250|UniProtKB:Q2TBE6}.
CC   -!- TISSUE SPECIFICITY: Detected in adult brain, especially in neurons in
CC       the cerebellum, brain cortex, dorsal root ganglion and spinal cord (at
CC       protein level). {ECO:0000269|PubMed:19581584}.
CC   -!- PTM: Ubiquitinated by ITCH; this does not lead to proteasomal
CC       degradation. {ECO:0000250|UniProtKB:Q9BTU6}.
CC   -!- PTM: Palmitoylated (PubMed:11244087). Palmitoylated by ZDHHC3 and
CC       ZDHHC7 in the CCPCC motif. Palmitoylation is cholesterol-dependent, and
CC       required for TGN localization (By similarity).
CC       {ECO:0000250|UniProtKB:Q9BTU6, ECO:0000269|PubMed:11244087}.
CC   -!- SIMILARITY: Belongs to the PI3/PI4-kinase family. Type II PI4K
CC       subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY029199; AAK33002.1; -; mRNA.
DR   RefSeq; NP_446187.1; NM_053735.1.
DR   AlphaFoldDB; Q99M64; -.
DR   SMR; Q99M64; -.
DR   BioGRID; 250373; 1.
DR   IntAct; Q99M64; 3.
DR   MINT; Q99M64; -.
DR   STRING; 10116.ENSRNOP00000019874; -.
DR   iPTMnet; Q99M64; -.
DR   PhosphoSitePlus; Q99M64; -.
DR   SwissPalm; Q99M64; -.
DR   jPOST; Q99M64; -.
DR   PaxDb; 10116-ENSRNOP00000019874; -.
DR   Ensembl; ENSRNOT00000019874.3; ENSRNOP00000019874.1; ENSRNOG00000014675.3.
DR   Ensembl; ENSRNOT00055006365; ENSRNOP00055004859; ENSRNOG00055003993.
DR   Ensembl; ENSRNOT00060049119; ENSRNOP00060040998; ENSRNOG00060028264.
DR   Ensembl; ENSRNOT00065048649; ENSRNOP00065039886; ENSRNOG00065028245.
DR   GeneID; 114554; -.
DR   KEGG; rno:114554; -.
DR   UCSC; RGD:620485; rat.
DR   AGR; RGD:620485; -.
DR   CTD; 55361; -.
DR   RGD; 620485; Pi4k2a.
DR   eggNOG; KOG2381; Eukaryota.
DR   GeneTree; ENSGT00390000010434; -.
DR   HOGENOM; CLU_032516_2_0_1; -.
DR   InParanoid; Q99M64; -.
DR   OMA; ELNIVPC; -.
DR   OrthoDB; 1332545at2759; -.
DR   PhylomeDB; Q99M64; -.
DR   TreeFam; TF314740; -.
DR   Reactome; R-RNO-1660499; Synthesis of PIPs at the plasma membrane.
DR   Reactome; R-RNO-1660514; Synthesis of PIPs at the Golgi membrane.
DR   Reactome; R-RNO-1660516; Synthesis of PIPs at the early endosome membrane.
DR   PRO; PR:Q99M64; -.
DR   Proteomes; UP000002494; Chromosome 1.
DR   Bgee; ENSRNOG00000014675; Expressed in cerebellum and 19 other cell types or tissues.
DR   GO; GO:0031083; C:BLOC-1 complex; ISO:RGD.
DR   GO; GO:0031410; C:cytoplasmic vesicle; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IDA:RGD.
DR   GO; GO:0005768; C:endosome; IDA:UniProtKB.
DR   GO; GO:0070382; C:exocytic vesicle; IDA:RGD.
DR   GO; GO:0098978; C:glutamatergic synapse; ISO:RGD.
DR   GO; GO:0000139; C:Golgi membrane; ISO:RGD.
DR   GO; GO:0035838; C:growing cell tip; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0005739; C:mitochondrion; ISS:UniProtKB.
DR   GO; GO:0043005; C:neuron projection; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IDA:RGD.
DR   GO; GO:0005886; C:plasma membrane; ISS:UniProtKB.
DR   GO; GO:0048786; C:presynaptic active zone; ISO:RGD.
DR   GO; GO:0042734; C:presynaptic membrane; ISS:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:RGD.
DR   GO; GO:0030672; C:synaptic vesicle membrane; IDA:RGD.
DR   GO; GO:0005802; C:trans-Golgi network; IBA:GO_Central.
DR   GO; GO:0004430; F:1-phosphatidylinositol 4-kinase activity; IDA:RGD.
DR   GO; GO:0035651; F:AP-3 adaptor complex binding; ISS:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; ISS:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:RGD.
DR   GO; GO:0002561; P:basophil degranulation; IMP:RGD.
DR   GO; GO:0007032; P:endosome organization; IBA:GO_Central.
DR   GO; GO:0007030; P:Golgi organization; IBA:GO_Central.
DR   GO; GO:0006661; P:phosphatidylinositol biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0046854; P:phosphatidylinositol phosphate biosynthetic process; ISO:RGD.
DR   InterPro; IPR039756; Lsb6/PI4K2.
DR   InterPro; IPR000403; PI3/4_kinase_cat_dom.
DR   PANTHER; PTHR12865:SF7; PHOSPHATIDYLINOSITOL 4-KINASE TYPE 2-ALPHA; 1.
DR   PANTHER; PTHR12865; PHOSPHATIDYLINOSITOL 4-KINASE TYPE-II; 1.
DR   Pfam; PF00454; PI3_PI4_kinase; 1.
DR   SUPFAM; SSF56399; ADP-ribosylation; 1.
DR   PROSITE; PS50290; PI3_4_KINASE_3; 1.
PE   1: Evidence at protein level;
KW   Acetylation; ATP-binding; Cell membrane; Cell projection;
KW   Cytoplasmic vesicle; Endosome; Golgi apparatus; Kinase; Lipid metabolism;
KW   Lipoprotein; Membrane; Mitochondrion; Nucleotide-binding; Palmitate;
KW   Phosphoprotein; Reference proteome; Synapse; Synaptosome; Transferase;
KW   Ubl conjugation.
FT   CHAIN           1..478
FT                   /note="Phosphatidylinositol 4-kinase type 2-alpha"
FT                   /id="PRO_0000285160"
FT   DOMAIN          123..452
FT                   /note="PI3K/PI4K catalytic"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          1..57
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          129..135
FT                   /note="G-loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          156..158
FT                   /note="Important for substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   REGION          164..177
FT                   /note="Important for interaction with membranes"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   REGION          267..275
FT                   /note="Important for interaction with membranes"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   REGION          304..312
FT                   /note="Catalytic loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          343..363
FT                   /note="Activation loop"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00269"
FT   REGION          358..367
FT                   /note="Important for interaction with membranes"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   BINDING         130..136
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   BINDING         151
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   BINDING         260..263
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   BINDING         345
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   MOD_RES         5
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         9
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   MOD_RES         43
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   MOD_RES         46
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100,
FT                   ECO:0007744|PubMed:22673903"
FT   MOD_RES         50
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16641100"
FT   MOD_RES         461
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:22673903"
FT   LIPID           173
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   LIPID           174
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   LIPID           176
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   LIPID           177
FT                   /note="S-palmitoyl cysteine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9BTU6"
FT   MUTAGEN         60
FT                   /note="L->A: Reduces targeting to synaptic vesicles and
FT                   neurite tips; when associated with A-61."
FT                   /evidence="ECO:0000269|PubMed:21998198"
FT   MUTAGEN         61
FT                   /note="L->A: Reduces targeting to synaptic vesicles and
FT                   neurite tips; when associated with A-60."
FT                   /evidence="ECO:0000269|PubMed:21998198"
SQ   SEQUENCE   478 AA;  54305 MW;  EBE4BFFB4574FD1F CRC64;
     MDETSPLVSP ERAQPPEYTF PSVSGAHFPQ VPGGAVRVAA AGSGPSPPCS PGHDRERQPL
     LDRARGAAAQ GQTHTVAAQA QALAAQAAVA VHAVQTHRER NDFPEDPEFE VVVRQAEIAI
     ECSIYPERIY QGSSGSYFVK DSQGRIIAVF KPKNEEPYGN LNPKWTKWLQ KLCCPCCFGR
     DCLVLNQGYL SEAGASLVDQ KLELNIVPRT KVVYLASETF NYSAIDRVKS RGKRLALEKV
     PKVGQRFNRI GLPPKVGSFQ LFVEGYKDAD YWLRRFEAEP LPENTNRQLL LQFERLVVLD
     YIIRNTDRGN DNWLIKYDYP MDNPNCRDTD WVMVREPVIK VAAIDNGLAF PLKHPDSWRA
     YPFYWAWLPQ AKVPFSQEIK DLILPKISDP NFVKDLEEDL YELFKKDPGF DRGQFHKQIA
     VMRGQILNLT QALKDNKSPL HLVQMPPVIV ETARSHQRSS SESYTQSFQS RKPFFSWW
//
